Who owns NRIX?
Institutional ownership of Nurix Therapeutics Inc. from Form 13F, Q2 2026
211 institutional managers reported holding Nurix Therapeutics Inc. (NRIX) in Form 13F filings for Q2 2026, with 117,340,812 shares worth $2.8B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 12,655 shares (+0.0%). 44 opened new positions and 27 sold out.
- Funds holding
- 211
- Value held
- $2.8B
- New / sold out
- 44 / 27
- Net shares, same filers
- +0.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of NRIX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $213M | 7.5% | 8,770,349 | Trimmed |
| Vestal Point Capital, LP | $195M | 6.9% | 8,050,000 | Added |
| Deep Track Capital, LP | $188M | 6.6% | 7,736,455 | Added |
| Rubric Capital Management LP | $175M | 6.2% | 7,227,778 | Added |
| FMR LLC | $133M | 4.7% | 5,485,215 | Trimmed |
| Price T Rowe Associates Inc | $132M | 4.6% | 5,436,587 | Added |
| Morgan Stanley | $116M | 4.1% | 4,762,484 | Trimmed |
| State Street Corp | $113M | 4.0% | 4,677,244 | Trimmed |
| Baker Bros. Advisors LP | $113M | 4.0% | 4,658,556 | Unchanged |
| Vanguard Capital Management LLC | $109M | 3.8% | 4,495,529 | Added |
| Perceptive Advisors LLC | $105M | 3.7% | 4,320,422 | Added |
| Redmile Group, LLC | $98.8M | 3.5% | 4,073,787 | Trimmed |
| General Atlantic, L.p. | $73.6M | 2.6% | 3,032,185 | Trimmed |
| Geode Capital Management, LLC | $61.6M | 2.2% | 2,537,291 | Added |
| Pictet Asset Management Holding SA | $57.0M | 2.0% | 2,351,232 | Trimmed |
| ARK Investment Management LLC | $43.5M | 1.5% | 1,793,196 | Added |
| Capital World Investors | $43.4M | 1.5% | 1,787,916 | Added |
| Trails Edge Capital Partners, LP | $38.2M | 1.3% | 1,573,220 | Trimmed |
| Vanguard Portfolio Management LLC | $36.0M | 1.3% | 1,482,861 | Added |
| Citadel Advisors LLC | $35.8M | 1.3% | 1,477,019 | Added |
| Soleus Capital Management, L.P. | $35.5M | 1.2% | 1,465,163 | Added |
| Dimensional Fund Advisors LP | $34.7M | 1.2% | 1,431,317 | Added |
| Eventide Asset Management, LLC | $31.5M | 1.1% | 1,297,893 | Unchanged |
| Braidwell LP | $31.2M | 1.1% | 1,286,769 | Trimmed |
| Kynam Capital Management, LP | $29.0M | 1.0% | 1,194,757 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 117,340,812 NRIX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Rubric Capital Management LP Added+$115M
- Price T Rowe Associates Inc Added+$52.1M
- Vestal Point Capital, LP Added+$37.6M
- Deep Track Capital, LP Added+$33.8M
- Capital World Investors Added+$21.7M
- Dimensional Fund Advisors LP Added+$15.8M
- Perceptive Advisors LLC Added+$14.8M
- Soleus Capital Management, L.P. Added+$12.8M
- Sofinnova Investments, Inc. New+$12.7M
- Arrowstreet Capital, Limited Partnership New+$11.6M
Biggest sellers in Q2 2026
- Redmile Group, LLC Trimmed-$88.8M
- Deutsche Bank Ag\ Trimmed-$52.0M
- Commodore Capital LP Sold out-$35.3M
- General Atlantic, L.p. Trimmed-$26.0M
- Longaeva Partners L.P. Sold out-$23.1M
- Millennium Management LLC Trimmed-$12.7M
- Goldman Sachs Group Inc Trimmed-$12.3M
- Braidwell LP Trimmed-$11.3M
- State Street Corp Trimmed-$11.3M
- Integral Health Asset Management, LLC Sold out-$10.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $445M and sold $394M; 67 added and 63 trimmed.
Schedule 13D and 13G filings on NRIX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-09-23PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Nurix Therapeutics Inc.Schedule 13G
- 2026-08-14PRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G filed by Nurix Therapeutics Inc.Schedule 13G
- 2026-05-06FMR LLC SCHEDULE 13G filed by Nurix Therapeutics Inc.Schedule 13G
Questions about NRIX ownership
- Who owns NRIX stock?
- 211 institutional investment managers reported NRIX positions in their Form 13F filings for Q2 2026, holding 117,340,812 shares worth $2.8B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling NRIX?
- In Q2 2026, 44 managers opened new NRIX positions, 67 added, 63 trimmed and 27 sold out. Managers that filed in both quarters added a net 12,655 shares.
- How current is this NRIX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to NRIX by CUSIP. Options are left out. NRIX news and filings · NRIX insider trades · Top funds